BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15251391)

  • 21. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
    Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
    Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
    Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decoy NF-kappaB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells.
    Lott DG; Dan O; Lu L; Strome M
    Laryngoscope; 2010 Jan; 120(1):44-52. PubMed ID: 19877191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients.
    Antonysamy MA; Steptoe RJ; Khanna A; Rudert WA; Subbotin VM; Thomson AW
    J Immunol; 1998 Apr; 160(8):4106-13. PubMed ID: 9558122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of regulatory dendritic cells by topical application of NF-kappaB decoy oligodeoxynucleotides.
    Isomura I; Shintani Y; Yasuda Y; Tsujimura K; Morita A
    Immunol Lett; 2008 Aug; 119(1-2):49-56. PubMed ID: 18547648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-tolerance of recipient-derived transforming growth factor-beta dendritic cells.
    Tiao MM; Lu L; Huang LT; Liang CD; Chen CL; Tao R; Fung JJ; Qian S
    Transplant Proc; 2007; 39(1):281-2. PubMed ID: 17275522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
    PĂȘche H; Heslan M; Usal C; Amigorena S; Cuturi MC
    Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
    Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S
    Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.
    Zahorchak AF; Kean LS; Tokita D; Turnquist HR; Abe M; Finke J; Hamby K; Rigby MR; Larsen CP; Thomson AW
    Transplantation; 2007 Jul; 84(2):196-206. PubMed ID: 17667811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models.
    Stax AM; Gelderman KA; Schlagwein N; Essers MC; Kamerling SW; Woltman AM; van Kooten C
    Transplantation; 2008 Nov; 86(9):1275-82. PubMed ID: 19005410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
    Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
    J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness.
    Emmer PM; van der Vlag J; Adema GJ; Hilbrands LB
    Transplantation; 2006 May; 81(10):1451-9. PubMed ID: 16732184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.
    Fu F; Li Y; Qian S; Lu L; Chambers F; Starzl TE; Fung JJ; Thomson AW
    Transplantation; 1996 Sep; 62(5):659-65. PubMed ID: 8830833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides.
    Xu MQ; Suo YP; Gong JP; Zhang MM; Yan LN
    World J Gastroenterol; 2004 Aug; 10(16):2361-8. PubMed ID: 15285020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice.
    Zhu XH; Chen S; Chen ZK
    Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic T-cell apoptosis induced by interleukin-10-modified dendritic cells: a mechanism of prolongation of intestine allograft survival?
    Zhu M; Wei MF; Liu F; Shi HF; Wang G; Chen S
    Transplant Proc; 2004 Oct; 36(8):2436-7. PubMed ID: 15561271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of acute and chronic allograft rejection by combinations of tolerogenic dendritic cells.
    Huang YL; Wang YZ; Chen JB; Wang F; Kang XP; Xia JJ; Lan TS; Xie BY; Ekberg H; Wang XM; Qi ZQ
    Scand J Immunol; 2011 Feb; 73(2):91-101. PubMed ID: 21198749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
    Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.